Finally: Clinical Trial Speed and Quality

Clinical operations quality control is a major issue in today’s Life Sciences market. The current method of getting drugs and medical devices through the clinical trial process is broken because of a lack of process transparency and data holes. According to CenterWatch, 86 percent of clinical trials experience delays, due to a data quality gap. Additionally, under 10 percent of clinical trials are completed on time. The root cause: poor data quality that slows down results and go-to-market. Old processes will no longer work and Life Sciences companies need to embrace the power of new technologies to modernize clinical trials.
[Read more…]

Year Before Europe’s New Clinical Trials Regulation Take Effect, Pharma Companies Must Prepare For A Tough Compliance Challenge

Next year about this time, the European Union will implement a new clinical trial regulation (EU CTR) meant to help pharmaceutical companies by offering clear and consistent rules for conducting clinical trials. The new regulation, EU CTR 536/2014, adopted last year and scheduled to take effect in May 2016 is intended to simplify a previous set of requirements governing clinical trials.
[Read more…]

Six Steps to Successful Sample Management

Effective sample management is critical to the overall success of a clinical trial, however it is often one of the most overlooked aspects of a clinical research project. The loss of data due to damaged samples or inaccurate documentation can cause a clinical trial to be repeated, or can prevent valuable therapies or devices from ever coming to market.
However, by putting some time in up front, many of these challenges can be avoided. Below are six smart ways pharmaceutical companies can avoid these common pitfalls that plague the clinical research industry.
[Read more…]